PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 24 No. 12
Pages: 1  2  
Previous
 

Between Pain and Addiction

By Cynthia M. A. Geppert, MD, PhD, MPH | October 1, 2007
Dr Geppert is chief of behavioral care consultation and ethics at the New Mexico Veterans Affairs Health Care System in Albuquerque. She is also assistant professor in the department of psychiatry and director of ethics education at the New Mexico School of Medicine and associate director of religious studies at the University of New Mexico in Albuquerque.

A 2000 study of the New York Medical Society found that 60% of the 1320 respondents were concerned about being investigated if they used opioids to treat chronic pain for longer than a month.8 The final, and I would argue most powerful, internal obstacle that prevents physicians from providing adequate pain treatment is a fear that a patient will lie, manipulate, or betray the fiduciary trust of the physician. The narcissistic injury sustained when a patient takes more drugs than prescribed, has a positive random toxicology screen, or is found to be taking medications from another provider is greatly underestimated and much more intense when it involves narcotics, at least in part because of the paralytic influence of the pervasive "war on drugs."9

Case 2: Charybdis

Mr P is a 49-year-old unemployed former mine worker who was admitted to the inpatient psychiatric facility after making a suicidal gesture ostensibly because of his unrelieved chronic pain that "hurts all over." Records were replete with drug-seeking behavior such as insistence that "only Percocet helps" and failure to follow up with counseling or rehabilitative therapy. During the past year, Mr P had begun using a wheelchair and was rarely ambulatory because of the intense pain. Community providers had prescribed the maximum dose of acetaminophen and oxycodone(Drug information on oxycodone) (Percocet), along with benzodiazepines to treat what seemed to be intractable pain. Collateral information revealed decades of marijuana and alcohol(Drug information on alcohol) dependence, with recent drinking to the point of intoxication and increasing cognitive deficits.

Comprehensive pain assessment, including neurological workup; cervical and lumbar MRI; physical therapy evaluation; and laboratory screening for rheumatological, metabolic, and other medical causes of pain was essentially negative. Pain specialists recommended humane tapering of opioids and benzodiazepines and aggressive substance abuse treatment. Cognitive and affective disturbances responded rather rapidly to reduction in narcotics.

In this case, both clinicians and patient have been sucked into the ever- expanding vortex of substance dependence with detrimental consequences for patient, family, and community. The 2005 National Survey on Drug Use and Health10 estimated that 4.7 million people had used narcotic pain relievers for nonmedical purposes in the month before the survey. Significantly, 60% stated they had obtained the drugs from a friend or relative, while about 17% stated they had received the drug from a doctor.10 A 2003 review of addiction rates among patients with chronic pain who were given opioids ranged from 3.2% to 18.9%, figures consistent with earlier studies.11

The threat of government sanction, although likely magnified in the minds of practitioners, is nonetheless real.12 As of 2005, 5600 physicians had been investigated on suspicion of drug diversion and more than 450 had been charged with illegal prescribing, drug trafficking, and even murder. Guidance from the federal government has been contradictory and intimidating, creating a climate of "high expressed emotion" characteristic of double-bind situations.13 The nadir of this confusion was the Drug Enforcement Administration's (DEA) 2004 retraction of its "frequently asked questions" document posted in the Federal Register, which had originally been seen as expressing a more moderate position toward legitimate pain medicine. The DEA indicated that the document contained "misstatements," particularly regarding physician practices that if misinterpreted could lead to increased scrutiny.14

A small group of rogue physicians running pain mills surely deserve the strong arm of the law and many others suffer from the woeful lack of continuing education, coordination, and communication between the historically separate and disparate pain and addiction communities. Others may lack the initiative, time, interest, or resources to perform the careful assessment, methodical monitoring, and intensive counseling required to safely and successfully treat chronic pain in patients using opioids, particularly those with a substance use proclivity or problem.15 However, the vast majority of physicians are simply trying to live out their oath of providing compassionate care to suffering patients.

Experts tell us that chronic pain is always partly subjective, and clinical epidemiology can never predict with absolute certainty which patient given opioids will return to the land of the living and which will go down to the street to deal death. This uncertainty places us squarely between the rock of abandoning the field of pain management and the hard place of prescription drug abuse. In my next column, I will try to chart a course between the 2 monsters and recommend psychiatrists as the most skilled pilots to navigate the straits of the dilemma.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





References

1. Homer. The Odyssey. Cook A, trans-ed. New York: Norton; 1967.
2. Radice B. Who's Who in the Ancient World. Baltimore: Stein and Day; 1971.
3. Pain Management. Washington, DC: Department of Veterans Affairs, Veterans Health Administration; 2003. VHA Directive 2003-021.
4. Chronic Pain in America: Roadblocks to Relief. American Pain Society Web site. Available at: http://www. ampainsoc.org/links/roadblocks/. Accessed May 21, 2007.
5. Breitbart W, Rosenfeld BD, Passik SD, et al. The undertreatment of pain in ambulatory AIDS patients. Pain. 1996;65:243-249.
6. Stannard C, Johnson M. Chronic pain management—can we do better? An interview-based survey in primary care. Curr Med Res Opin. 2003;19:703-706.
7. Jung B, Reidenberg MM. The risk of action by the Drug Enforcement Administration against physicians prescribing opioids for pain. Pain Med. 2006;7:353-357.
8. Cheng GS. Regulatory Scrutiny Cited in Pain Undertreatment. Fam Pract News. 2000.
9. Rich BA. The doctor as double agent. Pain Med. 2005; 6:393-396.
10. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Rockville, Md: Department of Health and Human Services; 2006.
11. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs. 2003;63:17-32.
12. Roosevelt M. Why is the DEA hounding this doctor? TIME magazineWeb site. July 18, 2005. Available at: http://www.time.com/time/magazine/article/0,9171,1083911,00.html. Accessed May 21, 2007.
13. Satel S. Doctors behind bars: treating pain is now risky business. New York Times. October 19, 2004. Available at: http://www.nytimes.com/2004/10/19/health/policy/19essa.html?pagewanted=2&ei=5070&en=c74f21fab1015f3f&ex=1179892800. Accessed May 21, 2007.
14. Robeznieks A. Removal of FAQs about prescriptions on DEA Web site causes turmoil. American Medical News. December 20, 2004. Available at: http://www.ama-assn.org/amednews/2004/12/20/prse1220.htm. Accessed May 21, 2007.
15. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18(4 suppl):S28-S38.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • The Moral Struggles of Practicing Psychiatrists
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Journey of the Traumatized Hero: Kerouac’s On the Road and Gandhi’s Railroad Ride
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
  • New Insight Into the Neurobiology of Depression
  • Cultural Psychiatry and the 'No-Chicken' Doctor
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy